BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37573316)

  • 1. Brazilian XP-E siblings carrying a novel DDB2 variant developed early-onset melanoma: a case report.
    de Souza Timoteo AR; Pinheiro de Almeida IC; Yurchenko AA; de Miranda Henriques SR; de Souza Segundo P; Rajabi F; Nikolaev S; Petta TB
    BMC Med Genomics; 2023 Aug; 16(1):186. PubMed ID: 37573316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel DDB2 mutation in a Chinese Han family with Xeroderma pigmentosum group E:a case report and literature review.
    Yang R; Kong Q; Duan Y; Li W; Sang H
    BMC Med Genet; 2020 Mar; 21(1):67. PubMed ID: 32228487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
    Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
    Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole Exome Sequencing allows the identification of two novel groups of Xeroderma pigmentosum in Tunisia, XP-D and XP-E: Impact on molecular diagnosis.
    Ben Rekaya M; Naouali C; Messaoud O; Jones M; Bouyacoub Y; Nagara M; Pippucci T; Jmel H; Chargui M; Jerbi M; Alibi M; Dallali H; Bashamboo A; McElreavey K; Romeo G; Barakat A; Zghal M; Yacoub-Youssef H; Abdelhak S
    J Dermatol Sci; 2018 Feb; 89(2):172-180. PubMed ID: 29169765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm.
    Kraemer KH; Lee MM; Andrews AD; Lambert WC
    Arch Dermatol; 1994 Aug; 130(8):1018-21. PubMed ID: 8053698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.
    Itoh T
    J Dermatol Sci; 2006 Feb; 41(2):87-96. PubMed ID: 16325378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts.
    Nikolaev S; Yurchenko AA; Sarasin A
    Orphanet J Rare Dis; 2022 Mar; 17(1):104. PubMed ID: 35246173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma.
    Sidwell RU; Sandison A; Wing J; Fawcett HD; Seet JE; Fisher C; Nardo T; Stefanini M; Lehmann AR; Cream JJ
    Br J Dermatol; 2006 Jul; 155(1):81-8. PubMed ID: 16792756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Xeroderma Pigmentosum in Japan: Lessons From Two Clinical Surveys and Measures for Patient Care.
    Nishigori C; Nakano E; Masaki T; Ono R; Takeuchi S; Tsujimoto M; Ueda T
    Photochem Photobiol; 2019 Jan; 95(1):140-153. PubMed ID: 30565713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma and other skin cancers in xeroderma pigmentosum patients and mutation in their cells.
    Takebe H; Nishigori C; Tatsumi K
    J Invest Dermatol; 1989 May; 92(5 Suppl):236S-238S. PubMed ID: 2715657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and molecular epidemiological study of xeroderma pigmentosum in China: A case series of 19 patients.
    Zhou EY; Wang H; Lin Z; Xu G; Ma Z; Zhao J; Feng C; Duo L; Yin J; Yang Y
    J Dermatol; 2017 Jan; 44(1):71-75. PubMed ID: 27607234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.
    Bradford PT; Goldstein AM; Tamura D; Khan SG; Ueda T; Boyle J; Oh KS; Imoto K; Inui H; Moriwaki S; Emmert S; Pike KM; Raziuddin A; Plona TM; DiGiovanna JJ; Tucker MA; Kraemer KH
    J Med Genet; 2011 Mar; 48(3):168-76. PubMed ID: 21097776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xeroderma pigmentosum group C in a French Caucasian patient with multiple melanoma and unusual long-term survival.
    Jacobelli S; Soufir N; Lacapere JJ; Regnier S; Bourillon A; Grandchamp B; Hétet G; Pham D; Palangie A; Avril MF; Dupin N; Sarasin A; Gorin I
    Br J Dermatol; 2008 Sep; 159(4):968-73. PubMed ID: 18717677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of effective skin cancer treatment and prevention in xeroderma pigmentosum.
    Lambert WC; Lambert MW
    Photochem Photobiol; 2015; 91(2):475-83. PubMed ID: 25382223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of phenotype/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations.
    Opletalova K; Bourillon A; Yang W; Pouvelle C; Armier J; Despras E; Ludovic M; Mateus C; Robert C; Kannouche P; Soufir N; Sarasin A
    Hum Mutat; 2014 Jan; 35(1):117-28. PubMed ID: 24130121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum.
    Cleaver JE
    J Dermatol Sci; 2000 May; 23(1):1-11. PubMed ID: 10699759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
    Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome.
    Oh KS; Khan SG; Jaspers NG; Raams A; Ueda T; Lehmann A; Friedmann PS; Emmert S; Gratchev A; Lachlan K; Lucassan A; Baker CC; Kraemer KH
    Hum Mutat; 2006 Nov; 27(11):1092-103. PubMed ID: 16947863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. True XP group E patients have a defective UV-damaged DNA binding protein complex and mutations in DDB2 which reveal the functional domains of its p48 product.
    Rapić-Otrin V; Navazza V; Nardo T; Botta E; McLenigan M; Bisi DC; Levine AS; Stefanini M
    Hum Mol Genet; 2003 Jul; 12(13):1507-22. PubMed ID: 12812979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The present status of xeroderma pigmentosum in Japan and a tentative severity classification scale.
    Nakano E; Masaki T; Kanda F; Ono R; Takeuchi S; Moriwaki S; Nishigori C
    Exp Dermatol; 2016 Aug; 25 Suppl 3():28-33. PubMed ID: 27539899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.